NewsBite

IVF

October 2024

The start-up revolutionising male fertility tests

A home testing kit for men helps avoid the inconvenience and embarrassment of trips to IVF clinics.

  • Michael Smith

September 2024

Donald Trump campaigns with far-right political group Moms for Liberty in Washington on the weekend.

Trump is a ‘deer in the headlights’ on one key issue

Heading into the campaign’s final stretch, Republicans careen between their base and swing voters on the powerful issue of reproductive rights.

  • Hannah Knowles and Cleve R. Wootson Jr.

August 2024

Hayley and Aaron Hughes with their children both born through IVF: Ned, now aged two, and Benson, who arrived last weekend.

IVF breakthrough shows AI just as good as humans, and much faster

A world-first study led by Australian researchers found an AI-powered embryo selection tool led to a similar number of pregnancies as human embryologists.

  • Tess Bennett

April 2024

Jessica Campbell, Google’s human resources lead in Australia and New Zealand, said the new family-building benefits would make employees feel more supported and valued.

Companies picking up the bill for employees’ egg freezing and IVF

Google has joined the growing ranks of companies offering financial reimbursements to staff for fertility treatments.

  • Euan Black

March 2024

Dr Nick Murphy founded GenEmbryomics in 2019.

Aussie IVF guru plans Nasdaq listing

GenEmbryomics founder Nick Murphy invented a test to screen embryos for genetic disorders. He wants to go public in the US, where the company’s customers live.

  • Tess Bennett
Advertisement

February 2024

Deciding when to stop IVF can be very difficult.

We’ve spent $40,000 on IVF. I want to continue, but my partner wants to stop

No one’s doing fertility treatment because they want it, says psychologist Narelle Dickinson, so make time for compassionate conversations and be honest.

  • Penny Wise
Only about 2 per cent of medical research funding is spent on pregnancy, childbirth and fertility.

Fertile forever: the research that is unlocking female fecundity

Philanthropist Nicole Shanahan is spending $100m to find answers to fundamental questions about ovaries.

  • Hannah Kuchler

June 2023

Marian Garriga, chief executive officer of Genea Biomedx, says AI enables deeper insights into embryo viability,

AI-powered IVF to be rolled out in Australian clinics

Artificial intelligence that helps embryologists select the most viable embryos has already been used successfully in Europe to boost pregnancy rates.

  • Jessica Sier

May 2023

Most local women are prevented from giving birth in the Gladstone hospital, unless by elective caesarean.

How ‘three-parent babies’ might change the human population’s future

The correcting of potential problems, critics fear, is also just a hair’s breadth from augmentation

  • Harry de Quetteville

April 2023

The elite couples breeding to save mankind

With global birth rates in free fall, Silicon Valley’s ‘pronatalists’ are aiming to halt the decline – by having as many babies as possible.

  • Io Dodds
Molly Benjamin, a financial literacy advocate, is in the process of freezing her eggs.

10 long reads for the weekend

The real reason Julian Leeser quit over the Voice; single women are paying a high price to have their eggs frozen; and meet Andrew Forrest’s hydrogen guy.

Ladies Finance Club founder Molly Benjamin is having her eggs frozen and documenting the process.

The big freeze – single women pay high price to call the shots

Technology is giving professional females a better shot at having children at a time of their choosing, but some are raiding their superannuation to achieve it.

  • Lucy Dean

June 2022

BGH is seeking to take its stake in Vertus to more than 90 per cent.

Virtus Health to pay special dividend

The takeover target will pay a fully franked dividend of up to 30¢ a share if BGH Capital acquires more than 90 per cent of the company by June 14.

  • Updated
  • Carrie LaFrenz

May 2022

BGH is seeking to take its stake to more than 50 per cent by Tuesday at 7pm.

Virtus special dividend slashed due to break fee

The board has spurned BGH Capital for months, but has finally agreed to provide it with access to a data room.

  • Carrie LaFrenz
Women in NSW undergoing IVF and accessing other assisted reproductive technologies will be given a cash rebate of up to $2,000 to reduce treatment costs

NSW to offer $2000 rebates for IVF treatment

The state government is looking to put women and families front and centre of the coming budget.

  • Updated
  • Natasha Boddy
Advertisement
Virtus’s independent expert and board now prefer BGH Capital’s offer over CapVest’s.

Virtus Health swaps horses to back BGH’s fresh bid

Sources suggested it is unlikely rival UK-based bidder CapVest Partners will up its bid again.

  • Carrie LaFrenz
The all-cash offer was recommended by Genea’s board.

Liverpool Partners in $202m bid for IVF provider Genea

As PE battles for Virtus Health, smaller rival Genea has a $202 million takeover of its own.

  • Anthony Macdonald, Sarah Thompson and Kanika Sood

April 2022

Bidding for the company started at $7.10 late last year, and Virtus has accepted CapVest’s offer of $8.25 per share for the IVF business.

Virtus board backs new higher offer from CapVest

After four months and eight bids, the IVF player is backing an increased offer from the UK-based PE firm, blocking rival BGH Capital’s latest move.

  • Updated
  • Carrie LaFrenz
CapVest Partners has lodged an application to the Takeovers Panel in the latest drama in the battle for Virtus.

Virtus suitor CapVest lodges new claim with Takeovers Panel

The UK-based PE firm is arguing that the market is not fully informed of what BGH’s maximum price might be ahead of selling shares to BGH under its latest offer.  

Australian IVF provider Virtus Health appears headed back into private equity ownership for the second time in a decade.

Virtus board sweats on new CapVest offer

Virtus Health is waiting on its eighth bid in just four months after the stock went into a trading halt on Thursday.

  • Updated

Original URL: https://www.afr.com/topic/in-vitro-fertilisation-1mxy